ArticleInvestigational new drugs2015

Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors.

Gerald S Falchook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.